Circulating betatrophin correlates with triglycerides and postprandial glucose among different glucose tolerance statuses - A case-control study

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Gao, Ting ^a   Jin, Kairui ^b   Chen, Peihong ^a   Jin, Hua ^a   Yang, Lili ^a   Xie, Xinmiao ^a   Yang, Meili ^a   Hu, Cheng ^a   Yu, Xuemei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETATROPHIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PANCREAS HORMONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CELL FUNCTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PATHOLOGY; POSTPRANDIAL STATE; REGRESSION ANALYSIS;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PEPTIDE HORMONES; POSTPRANDIAL PERIOD; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 84941909129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133640     Document Type: Article

References (21)

1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362:1090-1101. doi: 10.1056/NEJMoa0908292 PMID: 20335585
2. Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO. Managing type 2 diabetes: going beyond glycemic control. J Manag Care Pharm. 2008; 14: 2-19. PMID: 18597582
3. Bagust A, Beale S. Deteriorating beta-cell function in type 2 diabetes: a long-term model. QJM. 2003; 96:281-288. PMID: 12651972
4. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell. 2013; 153:747-758. doi: 10.1016/j.cell.2013.04.008 PMID: 23623304
5. Gusarova Viktoria, Alexa Corey A., Na Erqian, Stevis Panayiotis E., Xin Yurong, Susan Bonner-Weir, et al. ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion. Cell. 2014; 159: 691-696. doi: 10.1016/j.cell.2014.09.027 PMID: 25417115
6. Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia. 2014; 57: 50-53. PMID: 24078058
7. Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep. 2014; 4: 5013. doi: 10.1038/srep05013 PMID: 24852694
8. Espes D, Martinell M, Carlsson PO. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol.2014; doi: 10.1155/2014/323407
9. Gómez-Ambrosi J, Pascual E, Catalán V, Rodríguez A, Ramírez B, et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab. 2014; 99: E2004-E2009. doi: 10.1210/jc.2014-1568 PMID: 25050901
10. Fenzl A, Itariu BK, Kosi L, Fritzer-Szekeres M, Kautzky-Willer A, Stulnig TM, et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 2014; 57: 1204-1208. doi: 10.1007/s00125-014-3208-x PMID: 24623100
11. Hu H, Sun W, Yu S, Hong X, Qian W, Tang B, et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care. 2014; 37: 2718-2722. doi: 10.2337/dc14-0602 PMID: 25024395
12. Guo K 1, Lu J, Yu H, Zhao F, Pan P, Zhang L, et al. Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals. Obesity. 2015; 23: 793-797. doi: 10.1002/oby.21038 PMID: 25776943
13. Jiao Y, Le Lay J, Yu M, Naji A, Kaestner KH. Elevated mouse hepatic betatrophin expression does not increase human beta-cell replication in the transplant setting. Diabetes. 2014; 63: 1283-1288. doi: 10.2337/db13-1435 PMID: 24353178
14. Yi P, Park JS, Melton DA. Perspectives on the activities ofANGPTL8/betatrophin. Cell. 2014; 159: 467-468. doi: 10.1016/j.cell.2014.09.028 PMID: 25417096
15. Xie Xinmiao, Gao Ting, Yang Meili, Chen Peihong, Jin Hua, Yang Lili, et al. Associations of betatrophin levels with irisin in Chinese women with normal glucose tolerance. Diabetology & Metabolic Syndrome. 2015; 7:26.
16. Sanchis-Gomar F, Perez-Quilis C. The p38-PGC-1alpha-irisin-betatrophin axis: exploring new pathways in insulin resistance. Adipocytes. 2014; 3: 67-8.
17. Ren G 1, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2012; 303: E334-E351. doi: 10.1152/ajpendo.00084.2012 PMID: 22569073
18. Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E, et al. Atypical angiopoietin-like-protein that regulates ANGPTL3. Proc Natl Acad Sci USA. 2012; 109:19751-19756. doi: 10.1073/pnas.1217552109 PMID: 23150577
19. Wang Y, Quagliarini F, Gusarova V, Gromada J, Valenzuela DM, Cohen JC, et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA. 2013; 110: 16109-14. doi: 10.1073/pnas.1315292110 PMID: 24043787
20. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012; 424:786-792. doi: 10.1016/j.bbrc.2012.07.038 PMID: 22809513
21. Zhang R, Abou-Samra AB. Emerging roles of Lipasin as a critical lipid regulator. Biochem Biophys Res Commun. 2013; 432:401-405. doi: 10.1016/j.bbrc.2013.01.129 PMID: 23415864